Company profile
Rise Therapeutics company profile
Rise Therapeutics is focused on developing targeted immunological-based biologics using a unique and proprietary oral delivery platform. Rise leverages its target discovery expertise to understand microbiome gut biology as it relates to regulation of immune function.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2017-01-01, Year
Headquarters
- Headquarters
- Barbourmeade, Kentucky, United States
- Postal code
- 20850
- Country code
- US
- Continent
- North America